Medigen Vaccine Biologics Corporation (6547)
TWSE
Closed
Sep 14, 2026
Day's Range
56.5052 wk Range
33.50Overview - 6547 - Medigen Vaccine Biologics Corporation
Key Statistics
Valuation
Enterprise Value
20.10B
P/E (Trailing)
‪-71.39‬
P/E (Forward)
‪46.64‬
PEG Ratio
‪0.57‬
Price / Sales (TTM)
‪39.01‬
Price / Book
‪6.29‬
EV / EBITDA
‪-347.53‬
Profitability
Gross Margin
‪81.54%‬
Profit Margin
‪-29.06%‬
Operating Margin
‪18.58%‬
Return on Assets
‪-2.54%‬
Return on Equity
‪-4.61%‬
Ownership
Shares Outstanding
328.74M
Float
257.51M
Held by Insiders
‪23.80%‬
Held by Institutions
‪2.53%‬
Price stats
Beta
‪0.0040‬
50-Day Avg
‪51.61‬
200-Day Avg
‪45.21‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
1 analysts
Market Cap - 6547 - Medigen Vaccine Biologics Corporation
Peers - 6547 - Medigen Vaccine Biologics Corporation
Peer Comparison
Compared with companies in Biotechnology listed on TWSE.
Profile Summary - 6547 - Medigen Vaccine Biologics Corporation
About
Medigen Vaccine Biologics Corporation is a biotechnology company specializing in the research, development, and manufacturing of vaccines and biopharmaceuticals. Founded in 2012 and headquartered in Zhubei City, Taiwan, the company is dedicated to addressing global and regional infectious diseases, operating with…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
